Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn’s disease
January 29, 2024
Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn’s disease
Bian et al. (2017) RPTH 7, doi: 10.1002/dta.2250 Therapeutic drug monitoring of adalimumab is recommended…